Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06708715

Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment

The purpose of this research study is to collect subject perceptions or feelings about their treatment. Participation includes a survey from individuals who are receiving a stress or anxiety-relieving topical patch [Super Patch PEACE Patch with Haptic Vibrotactile Trigger Technology (VTT)] and assigned to a Treatment Group or given a Sham patch, assigned to the Control Group, to address symptoms or stress and anxiety symptoms using validated scales [for example, The Perceived Stress Scale (PSS) or Medical Outcomes Study Short Form-20 (SF-20)].

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Stress Anxiety Anxiety Disorders Mental Disorders

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stein Medical

Tyrone, Georgia, 30290, United States

About this study

This minimal risk observational study, will evaluate an over the counter (OTC) non-invasive, non- pharmacological patch (Super Patch PEACE Patch; The Super Patch Company Ltd LLC., SRYSTY Holding Co., Toronto, Canada) that is embedded with a proprietary sensory pattern and incorporates haptic vibrotactile trigger technology (VTT) and designed to trigger neural pathways and circuits associated with stress, anxiety, and other cortical networks, with other study participants who receive an 'inactive' (Sham) patch without the embedded VTT technology. The sensory patterns within the active patches are in close symmetry between known EEG patterns and their role in modulating EEG and neuronal circuits within higher brain centers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages 18 to 85, inclusive
  • Able to provide written informed consent
  • Have received a PEACE Patch from their treating clinician if in treatment group.
  • Is a patient who has been diagnosed with experienced stress or anxiety related issues.
  • Have received a Sham Patch if assigned tot eh Control Group

Exclusion criteria

  • Use of drugs of abuse (illicit or prescription)
  • Pregnancy
  • Existing or planned implantation of Pacemaker or other electrical devices

Treatment and study plan

PEACE Patch

Device

A topical patch that incorporates a sensory pattern of vibrotactile haptic technology.

Topical Sham Patch

Device

Sham Patch that does not include vibrotactile haptic technology

Primary outcomes

  1. Changes in patient Perceived Stress Scale (PSS)

    Time frame: From enrollment to end of treatment at 2 weeks

    Changes in patient Perceived Stress Scale (PSS) overall scores among and between the treated group and the control group. The Perceived Stress Scale (PSS) score is calculated by adding the score for all 10 questions, after reversing the scores for Q4, 5, 7 and 8 (0=4, 1=3, 2=2, 3=1, 4=0). Total possible score = 40. PSS categorizes stress levels as either high (scores of between 27-40), moderate (scores between 14-26), or low (scores between 0-14).

  2. Changes in patient Medical Outcomes Study Short Form-20 (SF-20)

    Time frame: From enrollment to end of treatment at 2 weeks

    Changes in patient Medical Outcomes Study Short Form-20 (SF-20) for 6 domains among and between the treated group and the control group. There are 20 items and 6 domains in the SF-20 that are measured. These are Physical Functioning, Role Functioning, Social Functioning, Mental Health, Health Perceptions, and Pain. Except for the Pain domain, the higher the percentage, the better the quality-of-life is corresponding. For the Pain domain, the lower the percentage, the lower the amount of bodily pain is corresponding. For the Mental Health domain, the analysis represents the four major mental health dimensions. These are anxiety, depression, loss of behavioral-emotional control, and psychological well- being.

  3. Changes in the use of prescription and OTC medications

    Time frame: From enrollment to end of treatment at 2 weeks

    Changes in Number of Prescription Medications Used based on subject and clinician reporting through a questionnaire for those subjects in Treatment Arm and receiving the active patch (PEACE) or Control Sham patch during study period. Comparisons will be made between prescription medication usage reporting at baseline, 7-day, and 14 days.

  4. Demographics and patient satisfaction with the PEACE Patch treatment.

    Time frame: From enrollment to end of treatment at 2 weeks

    Demographics and patient satisfaction based on subject and clinician reporting for those subjects in Treatment Arm and receiving the active patch (PEACE) or Control Sham patch during study period.

Other outcomes

  1. Any side effects reported by patients will be documented and assessed by clinician and PI

    Time frame: From enrollment to end of treatment at 2 weeks

    Evaluation of reported side effects during study period based on self-report by subject or reported by clinician investigator.

Sponsors and collaborators

Lead sponsor

SuperPatch Limited LLC

Industry

Collaborators

  • Clarity Science LLC

Registry information

Acronym: STRAVA

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Nov 27, 2024
Registry last updated
Dec 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.